QTTB

Latest SEC Filings & News for QTTB

1 most recent filing and news item mentioning QTTB. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/QTTB/news?limit=20"

Pull QTTB filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
RegulatoryJul 13, 2026Positive

Q32 Bio Reports Positive Toppline Results From SIGNAL-AA Trial In Alopecia Areata

Q32 Bio announced positive toppline results from the SIGNAL-AA trial, showing a 35.3% mean reduction in SALT score. The data demonstrates a differentiated safety profile and efficacy that positions bempikibart as a potential next-generation therapy for alopecia areata.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.